PPT-Medical Treatment Options for Cardiogenic Shock: When Is It Time to Escalate to Mechanical
Author : fauna | Published Date : 2023-06-10
Chris Domenico PharmD Cardiology and Anticoagulation Clinical Specialist Hospital of the University of Pennsylvania Disclosures Pfizer consultant fees Objectives
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Medical Treatment Options for Cardiogeni..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Medical Treatment Options for Cardiogenic Shock: When Is It Time to Escalate to Mechanical: Transcript
Chris Domenico PharmD Cardiology and Anticoagulation Clinical Specialist Hospital of the University of Pennsylvania Disclosures Pfizer consultant fees Objectives Describe the pharamaceutical. Technology. Emergent Support. Clinical . Evidence and . Investigations. The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: . Results from the USpella Registry. . Sarswat. , MD. Cardiology Fellow. Cardiogenic. Shock. Types of Shock. Distributive/Septic Shock: variable cardiac output, decreased SVR. Hypovolemic. Shock: decreased effective circulating volume. Hypotention. /shock. Reza . ghaderi. DR. 1393-spring . Definition. Shock is a physiologic state characterized by a significant reduction of systemic tissue perfusion, resulting in decreased oxygen delivery to the tissues.. Eric. Alison. Lexi. Kevin. Article. http. ://byui.idm.oclc.org/login?url. =. http://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=24509521&site=ehost-live. Distributive shock . Types of Shock. Hypovolemic. Inadequate blood volume. Distributive. Inappropriately distributed blood volume and flow. Cardiogenic. Insufficient CO caused by poor myocardial function. Obstructive. Obstructed flow (into or out of the heart). DEPT OF PATHOLOGY AND MICROBIOLOGY . SKHMC. what is shock ?. Is a . final common pathway . for a number of serious or . potentially lethal clinical events- . e g. severe hemorrhage,. Extensive trauma or burns. Ruth Fisher, MBA. Henry Ford Health System. Vice President . Heart and Vascular Services. Detroit, MI. Detroit. C. ardiogenic. S. hock. I. nitiative. Detroit. . CSI. What is Detroit CSI. How did we start. November ‘22 – April ‘23. Aron, J. . Handslip. , R. O’Mara H. . Background. Cardiogenic shock results in multi-organ failure and high mortality.. 1. . It is classified into SCAI stages A-E, class C and above frequently present. William W. O’Neill, MD. Henry Ford Health System. Medical Director. Center for Structural Heart Disease. Detroit, MI. Diffuse Multivessel. Disease. . Border Zone. Dysfunction. Central Zone. Dyskinesis. Shock:. What Are the . Hemodynamics. ?. Jeff Davis, RRT, RCIS . Jeff Davis has nothing to disclose. Disclosures. Shock. Hippocrates perhaps first to describe shock . French surgeon Henri Francois Le . Farhan J. Khawaja MD, FACC, FSCAI, RPVI. OUTLINE. Definition of Cardiogenic Shock. Epidemiology- A Call to Action. Treatment of Cardiogenic Shock . Advances . in the Treatment of Cardiogenic Shock. . A.L. Mohammed Kareem . 2. 2020-2021. Definition: . Shock is a life-threatening condition that occurs when the body is not getting enough blood . flow(. hypoprefusion. ). . Lack of blood flow means the cells and organs do not get enough oxygen and nutrients to function properly. Many organs can be damaged as a result. Shock requires immediate treatment and can get worse very rapidly. As many 1 in 5 people who suffer shock will die . Profound hemodyamic and metabolic disturbance characterized by failure of the circulatory system to maintain adequate perfusion of vital organs. Types of Shock. Cardiogenic (intracardiac vs extracardiac). George W. Vetrovec, MD, MACC, MSCAI. Professor Emeritus, VCU Pauley Heart Center. Virginia Commonwealth University. Richmond, Virginia . USA. Disclosures:. Consultant: Abiomed, Merck, FDA. What Hemodynamic Support is Available?.
Download Document
Here is the link to download the presentation.
"Medical Treatment Options for Cardiogenic Shock: When Is It Time to Escalate to Mechanical"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents